Clinical Trial Update: Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian [Phase 2, Phase 3]

View source ↗

Summary

This update reports completed Phase 2/3 data on the persistence of Vi antibodies and potential long-term protection from the Vi-DT conjugate typhoid vaccine tes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Vi-DT conjugate vaccine (Vi polysaccharide-tetanus toxoid conjugate vaccine)

Snippet

Sponsor: PT Bio Farma | Conditions: Vaccine | Phase 2, Phase 3 | Status: COMPLETED